Re-evaluation of the prolactin receptor expression in human breast cancer

Journal of Endocrinology

Volumn 201, Issue 1, 2009, Pages 115-128

  Galsgaard, Elisabeth Douglas ^a   Rasmussen, Birgitte Bruun ^b   Folkesson, Charlotta Grånäs ^a   Rasmussen, Louise Maymann ^a,c   Berchtold, Martin Werner ^c   Christensen, Leif ^a   Panina, Svetlana ^a  

^a NOVO NORDISK A S   (Denmark)

^b HILLERØD HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 18; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 250448; MONOCLONAL ANTIBODY B6.2; MONOCLONAL ANTIBODY H 300; MONOCLONAL ANTIBODY U5; PROLACTIN RECEPTOR; PROLACTIN RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; PROLACTIN;

ANTIBODY SPECIFICITY; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER CELL CULTURE; CELL SURFACE; CONTROLLED STUDY; CROSS REACTION; DECIDUA; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; PLACENTA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TISSUE SECTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BREAST TUMOR; CARCINOMA; CELL STRAIN HT29; CHO CELL; CRICETULUS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HAMSTER; IMMUNOLOGY; METABOLISM; PROTEIN BINDING; TISSUE MICROARRAY; TUMOR CELL CULTURE; VALIDATION STUDY;

ANIMALS; ANTIBODY SPECIFICITY; BREAST NEOPLASMS; CARCINOMA; CHO CELLS; CRICETINAE; CRICETULUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; PROLACTIN; PROTEIN BINDING; RECEPTORS, PROLACTIN; TISSUE ARRAY ANALYSIS; TUMOR CELLS, CULTURED;

EID: 67049084362     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0479     Document Type: Article

References (36)

1. Banerjee R, Ginsburg E & Vonderhaar BK 1993 Characterization of a monoclonal antibody against human prolactin receptors. International Journal of Cancer 55 712-721.
2. Ben-Jonathan N, LaPensee CR & LaPensee EW 2008 What can we learn from rodents about prolactin in humans? Endocrine Reviews 29 1-41.
3. Bhatavdekar JM, Patel DD, Shah NG, Vora HH, Suthar TP, Ghosh N, Chikhlikar PR & Trivedi TI 2000 Prolactin as a local growth promoter in patients with breast cancer: GCRI experience. European Journal of Surgical Oncology 26 540-547.
4. Bonneterre J, Peyrat JP, Beuscart R, Lefebvre J & Demaille A 1987 Prognostic significance of prolactin receptors in human breast cancer. Cancer Research 47 4724-4728.
5. Di Carlo R & Muccioli G 1979 Prolactin receptors in human mammary carcinoma. Tumori 65 695-702.
6. Clevenger CV, Chang W-P, Ngo W, Pasha TLM, Montone KT & Tomaszewski JE 1995 Expression of prolactin and prolactin receptor in human breast carcinoma: evidence for an autocrine/paracrine loop. American Journal of Pathology 146 695-705.
7. Clevenger CV, Furth PA, Hankinson SE & Shuler LA 2003 The role of prolactin in mammary carcinoma. Endocrine Reviews 24 1-27.
8. Colcher D, Hand PH, Nuti M & Schlom J 1981 A spectrum of monoclonal antibodies reactive with human mammary tumor cells. PNAS 78 3199-3203.
9. la Cour JM, Mollerup J, Winding P, Tarabykina S, Sehested M & Berchtold MW 2003 Up-regulation of ALG-2 in hepatomas and lung cancer tissue. American Journal of Pathology 163 81-89.
10. Gellersten B, Kempf R, Telgmann R & DiMattia GE 1994 Nonpituitary human prolactin transcription is dependent on pit-1 and differentially controlled in lymphocytes and I endometrial stroma. Molecular Endocrinology 8 356-373.
11. Gill G, Peston D, Vonderhaar BK & Shousha S 2001 Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study. Journal of Clinical Pathology 54 956-960.
12. Ginsburg E & Vonderhaar BK 1995 Prolactin synthesis and secretion by human breast cancer cells. Cancer Research 55 2591-2595.
13. Glasow A, Horn LC, Taymans SE, Stratakis CA, Kelly PA, Kohler U, Gillespie J, Vonderhaar BK & Bornstein SR 2001 Mutational analysis of the PRL receptor gene in human breast tumors with differential PRl receptor protein expression. Journal of Clinical Endocrinology and Metabolism 8 3826-3832.
14. Hand PH, Nuti M, Colcher D & Schlom J 1983 Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens. Cancer Research 43 728-735.
15. Hefler LA, Tempfer CB, Bancher-Todesca D, Schatten C, Husslein P, Heinze G & Gregg AR 2001 Placental expression and serum levels of cytokeratin-18 are increased in women with preeclampsia. Journal of the Society for Gynecologic Investigation 8 169-173.
16. Holdaway IM & Friesen HG 1977 Hormone binding by human mammary carcinoma. Cancer Research 37 1946-1952.
17. 125I-insulins. Diabetologia 19 546-554.
18. Kenner JR, Holaday JW, Bernton EW & Smith PF 1991 Prolactin-like protein in murine spenocytes: morphologic and biochemical evidence. Progress in Neuroendocrinoimmunology 3 188-195.
19. Kline JB, Roehrs H & Clevenger CV 1999 Functional characterization of the intermediate isoform of the human prolactin receptor. Journal of Biological Chemistry 274 35461-35468.
20. Kline JB, Rycyzyn MA & Clevenger CV 2002 Characterization of a novel and functional human prolactin receptor isoform (dS1PRLr) containing only one extracellular fibronectin-like domain. Molecular Endocrinology 16 2310-2322.
21. Maaskant RA, Bogic LV, Gilger S, Kelly PA & Bryant-Greenwood DB 1996 The human prolactin receptor in the fetal membranes, decidua and placenta. Journal of Clinical Endocrinology and Metabolism 81 396-405.
22. Meng J, Tsai-Morris CH & Dufau ML 2004 Human prolactin receptor variants in breast cancer: low ratio of short forms to the long-form human prolactin receptor associated with mammary carcinoma. Cancer Research 64 5677-5682.
23. Mertani HC, Garcia-Caballero T, Lambert A, Gérard F, Palayer C, Boutin JM, Vonderhaar BK, Waters MJ, Lobie PE & Morel G 1998 Cellular expression of growth hormone and prolactin receptors in human breast disorders. International Journal of Cancer 79 202-211.
24. Moll R, Franke WW & Schiller DL 1982 The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31 11-24.
25. Montgomery DW, LeFevre JA, Ulrich ED, Adamson CR & Zukovski CF 1990 Identification of prolactin-like proteins synthesized by normal murine lymphocytes. Endocrinology 127 2601-2603.
26. Ormandy CJ, Hall RE, Manning DL, Robertson JF, Blamey RW, Kelly PA, Nicholson RI & Sutherland RL 1997 Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer. Journal of Clinical Endocrinology and Metabolism 82 3692-3699.
27. Partridge RK & Hahnel R 1979 Prolactin receptors in human breast carcinoma. Cancer 43 643-646.
28. Peirce SK & Chen WY 2001 Quantification of prolactin receptor mRNA in multiple human. tissues and cancer cell lines by real time RT-PCR. Journal of Endocrinology 171 R1-R4.
29. Rae-Venter B, Nemoto T, Schneider SL & Dao TL 1981 Prolactin binding to human mammary carcinoma: relationship to estrogen receptor protein concentration and patient age. Breast Cancer Research and Treatment 1 233-243.
30. Reynolds C, Montone KT, Powell CM, Tomaszewski JE & Clevenger CV 1997 Expression of prolactin and its receptor in human breast carcinoma. Endocrinology 138 5555-5560.
31. Schneider C, Newman RA, Sutherland DR, Asser U & Greaves MF 1982 A one-step purification of membrane proteins using a high efficiency immunomatrix. Journal of Biological Chemistry 257 10766-10769.
32. Svensson LA, Bondensgaard K, Nørskov-Lauritsen L, Christensen L, Becker P, Andersen MD, Maltesen MJ, Rand KD & Breinholt J 2008 Crystal structure of a prolactin receptor antagonist bound to the extracellular domain of the prolactin receptor. Journal of Biological Chemistry 283 19085-19094.
33. Touraine P, Martini J-F, Zafrani B, Durand J-C, LaBaille F, Malet C, Nicolas A, Trivin C, Postel-Vinay M-C, Kuttenn F et al. 1998 Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues. Journal of Clinical Endocrinology and Metabolism 83 667-674.
34. Trott JF, Hovey RC, Koduri S & Vanderhaar BK 2003 Alternative splicing to exon 11 of human prolactin receptor gene results in multiple isoforms including a secreted prolcatin-binding protein. Journal of Molecular Endocrinology 30 31-47.
35. Turcot-Lemay L & Kelly PA 1982 Prolactin receptors in human breast tumors. Journal of the National Cancer Institute 68 381-383.
36. Woelfle U, Sauter G, Santjer S, Brakenhoff R & Pantel K 2004 Down-regulated expression of cytokeratin 18 promotes progression of human breast cancer. Clinical Cancer Research 10 2670-2674.